The global injectable cytotoxic drugs market is entering a sustained growth phase as healthcare systems confront an increasing burden of cancer and other chronic diseases requiring intensive pharmacological treatment. Valued at US$18.6 billion in 2023, the market is expected to expand at a 6.8% CAGR from 2024 to 2034, reaching approximately US$38.2 billion by 2034.👉 Get sample market research...